WAWang

Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chi Liu

    Department of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Xiangya Hospital, Central South University, China

    1 shared publication
  • Hui Xie

    Macao Polytechnic University

    1 shared publication
  • Huizhen Jia

    Department of Biochemistry & Molecular Biology Harbin Medical University Harbin Heilongjiang P.R. China

    1 shared publication
  • Ke Zhang

    School of Electrical Engineering, North China Electric Power University, Beijing, China

    1 shared publication
  • Ping Lin

    School of Mechanical and Electrical Engineering, Weifang University of Science and Technology, Weifang, 262700, China

    1 shared publication
  • Rou Li

    Key Laboratory of Concrete and Prestressed Concrete, Structures, Ministry of Education, Southeast, University, Nanjing 211189, P. R. China

    1 shared publication

Latest Publications

  • Apaf‐1 interacting protein, a new target of microRNA‐146a‐3p, promotes prostate cancer cell development via the ERK1/2 pathway

    by Nan Wang, Rou Li, Huizhen Jia, Hui Xie, Chi Liu, Shan Jiang, Ke Zhang, Ping Lin, Xiaoguang Yu

    The Apaf‐1 interacting protein (APIP), a ubiquitously expressed antiapoptotic molecule, is aberrantly expressed and of great significance in various cancers. However, little is known regarding the potential value and underlying mechanisms of APIP in prostate cancer. Here, we demonstrated that APIP expression is significantly upregulated in prostate cancer cell lines. APIP overexpression promoted tumor cell proliferation and migration and induced extracellular regulated protein kinases 1/2 (ERK1/2) activation. Pharmacological inhibition of ERK1/2 signaling reversed APIP‐induced increase in cell proliferation and migration induced by APIP overexpression. Expression of APIP was hampered by miR‐146a‐3p. A dual luciferase reporter gene assay identified the regulatory relationship between APIP and miR‐146a‐3p in prostate cancer, suggesting that APIP is a direct target of miR‐146a‐3p. miR‐146a‐3p reduced cell proliferation and migration in prostate cancer. Furthermore, miR‐146a‐3p inhibited ERK1/2 activation. Application of an ERK1/2 inhibitor reversed the increase in cell proliferation and migration induced by miR‐146a‐3p inhibition. In summary, this study focused on the role of APIP in regulating cell growth and migration and proposes a theoretical basis for APIP as a promising biomarker in prostate cancer development.